Covered recipient · General Payments record
YING LIU
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$1,135.67
- Reported across 50 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $597.38 | 36 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $146.65 | 9 |
| Lilly USA, LLC | $119.84 | 8 |
| Amgen Inc. | $73.38 | 5 |
| DEXCOM, INC. | $54.89 | 3 |
| Novo Nordisk AS | $51.05 | 3 |
| GlaxoSmithKline, LLC. | $38.00 | 2 |
| Abbott Laboratories | $33.54 | 2 |
| Hologic Sales and Service, LLC | $28.94 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.10 | 1 |
| Acerta Pharma LLC | $16.34 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.17 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240908451 | CMS |
| Abbott Laboratories | $19.37 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240944348 | CMS |
| ABBVIE INC. | $18.65 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315176 | CMS |
| ABBVIE INC. | $17.57 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315178 | CMS |
| ABBVIE INC. | $18.75 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315180 | CMS |
| ABBVIE INC. | $14.77 | 05/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315182 | CMS |
| ABBVIE INC. | $18.76 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315184 | CMS |
| ABBVIE INC. | $14.98 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315186 | CMS |
| ABBVIE INC. | $14.20 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315188 | CMS |
| ABBVIE INC. | $14.20 | 10/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315190 | CMS |
| ABBVIE INC. | $14.77 | 12/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202315192 | CMS |
| Amgen Inc. | $15.87 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228571247 | CMS |
| Amgen Inc. | $13.47 | 08/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227200024 | CMS |
| Amgen Inc. | $15.18 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228571245 | CMS |
| Amgen Inc. | $14.21 | 09/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227200026 | CMS |
| Amgen Inc. | $14.65 | 11/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227200022 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.34 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206132278 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.65 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242674819 | CMS |
| Dexcom, Inc. | $17.08 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250539226 | CMS |
| Dexcom, Inc. | $19.92 | 06/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250539228 | CMS |
| Dexcom, Inc. | $17.89 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250539230 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.10 | 05/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184547011 | CMS |
| GlaxoSmithKline, LLC. | $19.00 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190481511 | CMS |
| GlaxoSmithKline, LLC. | $19.00 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190421921 | CMS |
| Hologic Sales and Service, LLC | $28.94 | 04/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1182519501 | CMS |
| Lilly USA, LLC | $16.69 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186992424 | CMS |
| Lilly USA, LLC | $10.43 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187050471 | CMS |
| Lilly USA, LLC | $13.86 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187050473 | CMS |
| Lilly USA, LLC | $15.43 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186956343 | CMS |
| Lilly USA, LLC | $21.02 | 08/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187063512 | CMS |
| Lilly USA, LLC | $14.99 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186956345 | CMS |
| Lilly USA, LLC | $11.86 | 10/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187004258 | CMS |
| Lilly USA, LLC | $15.56 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186956347 | CMS |
| Novo Nordisk Inc | $16.19 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189033460 | CMS |
| Novo Nordisk Inc | $17.05 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188544702 | CMS |
| Novo Nordisk Inc | $17.81 | 08/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188448234 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.